Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Osteonecrosis of the jaw Stories

2013-11-07 15:37:01

A recent prospective, randomized, placebo-controlled clinical trial reports that calcium and vitamin D supplementation improves bone density in a group of male veterans with epilepsy who were treated chronically with antiepileptic drugs (AEDs). The results published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggest that risedronate, a bisphosphonate, may help to prevent new vertebral fractures when taken with calcium and vitamin D supplementation. Many...

2013-09-09 23:27:18

As Reuters reported on August 30, a federal judge overseeing consolidated litigation over jaw injuries allegedly caused by Fosamax ordered hundreds of Fosamax lawsuits readied for trial. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fosamax side effects. San Diego, CA (PRWEB) September 09, 2013 AttorneyOne.com, a recognized authority on...

2013-08-23 23:19:43

On August 15, a New York federal judge ruled in Fosamax Multidistrict Litigation that generic manufacturers can be held liable for failing to match their warning labels to the brand name label. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fosamax side effects. San Diego, CA (PRWEB) August 23, 2013 AttorneyOne.com, a recognized authority on...

2013-07-16 14:09:01

Excess fat around the belly has recently been identified as a risk factor for bone loss. Now, a new study has determined that excess liver and muscle fat also may be detrimental to bone. The study, published online in the journal Radiology, found that obese people with higher levels of fat in their liver, muscle tissue and blood also have higher amounts of fat in their bone marrow, putting them at risk for osteoporosis. "Obesity was once thought to be protective against bone loss," said...

2013-07-15 23:00:09

A new study, published online July 16th in the journal Radiology, found that obese people with higher levels of fat in their liver, muscle tissue and blood also have higher amounts of fat in their bone marrow, putting them at risk for osteoporosis. Oak Brook, Ill. (PRWEB) July 15, 2013 Excess fat around the belly has recently been identified as a risk factor for bone loss. Now, a new study has determined that excess liver and muscle fat also may be detrimental to bone. The study,...

2013-07-15 20:22:18

Phase 2 Study Reports Safety and Efficacy Results THOUSAND OAKS, Calif., July 15, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Lancet Oncology published planned interim results from an international, open-label, Phase 2 clinical trial that is evaluating XGEVA(®) (denosumab) in adults and skeletally mature adolescents diagnosed with giant cell tumor of bone (GCTB). The study's primary endpoint is the safety profile of XGEVA. Secondary endpoints are the time to disease...

2013-07-05 23:18:43

According to court documents, on July 1st, a US Federal judge denied Merck’s attempt to wipe out a $285,000 plaintiff verdict on Fosamax jaw deterioration. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fosamax side effects. San Diego, CA (PRWEB) July 05, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and...

2013-07-03 23:02:39

d'Oliveira & Associates has released a new infographic detailing the possible risks of Fosamax, including femur fractures and osteonecrosis of the jaw. (PRWEB) July 03, 2013 Fosamax (alendronate) is a drug that is used to treat bone conditions like osteoporosis. This drug is included in the bisphosphonate class of drugs which slow the process of bone loss. It was first approved by the FDA in September 1995. In December 2009 NPR reported that Fosamax has been a blockbuster drug...

2013-06-18 23:23:30

According to court data, on May 15 there were 1,064 cases pending in the Fosamax Multidistrict Litigation. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fosamax side effects. San Diego, CA (PRWEB) June 18, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in...

2013-06-13 16:26:36

XGEVA Becomes First FDA-Approved Treatment for This Rare Disease THOUSAND OAKS, Calif., June 13, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for XGEVA(®) (denosumab) for the treatment of adults and skeletally mature adolescents with giant cell tumor of bone (GCTB) that is unresectable or where surgical resection is likely to result in severe morbidity. XGEVA was approved following a...